Pharma Industry Broadens Its Approach To Expanded Access

Novartis co-leads industry forum on preapproval access that aims to share best practices and engage patient groups; Janssen is launching three pilots to leverage collection of preapproval access data.

Medical advice and medication guidance and prescription drugs health consultation as a giant pill shaped as a lighthouse beacon with 3D illustration elements. — Expanded access to investigational drugs involves reimbursement and supply hurdles

Expanded access to investigational products continues to evolve as pharma companies devote more resources to their programs and explore ways to engage patients and utilize data collected outside clinical trials. They are also grappling with reimbursement and supply challenges and how to provide equitable access.

Several company representatives shared their experiences with expanded access programs at a 13 January conference hosted by the New York...